Jin Medical International Changes Auditor; Board Approves Without Audit Committee
Summary
Jin Medical International Ltd. has changed its independent auditor, dismissing Audit Alliance LLP and engaging Enrome LLP, with the Board of Directors approving the change without separate Audit Committee recommendation or approval.
Key Events
-
Auditor Dismissal
Audit Alliance LLP was dismissed as the independent registered public accounting firm, effective June 2, 2026.
-
New Auditor Appointed
Enrome LLP has been engaged as the new independent registered public accounting firm for the fiscal year ending September 30, 2026.
-
No Disagreements Reported
The company stated that there were no adverse opinions, disclaimers, or disagreements with Audit Alliance LLP on accounting principles or auditing procedures.
-
Audit Committee Not Involved
The change was approved by the Board of Directors but was not separately recommended or approved by the Company's Audit Committee.
Analysis
Jin Medical International Ltd. has dismissed its independent registered public accounting firm, Audit Alliance LLP, and appointed Enrome LLP. While the company stated there were no disagreements or adverse opinions with the former auditor, the change was approved by the Board of Directors but not separately by the Audit Committee. This raises a governance concern, as the Audit Committee typically plays a primary role in auditor oversight and selection, especially for a micro-cap company.
At the time of this filing, ZJYL was trading at $2.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $25.1M. The 52-week trading range was $1.64 to $17.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.